Torrent Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
5,122.80
250.7 (5.15%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 18.99 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zydus Lifesci.
Lupin
Laurus Labs
Sun Pharma.Inds.
Mankind Pharma
Divi's Lab.
Biocon
Torrent Pharma
Aurobindo Pharma
Cipla
Dr Reddy's Labs

Why is Torrent Pharmaceuticals Ltd. ?

1
High Management Efficiency with a high ROCE of 21.88%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 3.30 times
3
Flat results in Jun 26
  • ROCE(HY) Lowest at 14.29%
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 5.46 times
  • DEBT-EQUITY RATIO(HY) Highest at 1.79 times
4
With ROCE of 16.1, it has a Very Expensive valuation with a 9.7 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 36.37%, its profits have risen by 10.7%
5
Consistent Returns over the last 3 years
  • Along with generating 36.37% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Torrent Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Torrent Pharma for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Torrent Pharma
36.9%
1.76
21.01%
Sensex
-3.81%
-0.28
13.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.80%
EBIT Growth (5y)
13.49%
EBIT to Interest (avg)
8.04
Debt to EBITDA (avg)
1.53
Net Debt to Equity (avg)
1.55
Sales to Capital Employed (avg)
0.90
Tax Ratio
24.80%
Dividend Payout Ratio
59.45%
Pledged Shares
0
Institutional Holding
30.84%
ROCE (avg)
22.98%
ROE (avg)
23.24%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
87
Industry P/E
37
Price to Book Value
23.26
EV to EBIT
56.56
EV to EBITDA
40.09
EV to Capital Employed
9.73
EV to Sales
13.24
PEG Ratio
NA
Dividend Yield
0.66%
ROCE (Latest)
16.09%
ROE (Latest)
26.24%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
NET SALES(Q)

Highest at Rs 4,921.00 cr

PBDIT(Q)

Highest at Rs 1,664.00 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 33.81%

-19What is not working for the Company
ROCE(HY)

Lowest at 14.29%

OPERATING PROFIT TO INTEREST (Q)

Lowest at 5.46 times

DEBT-EQUITY RATIO(HY)

Highest at 1.79 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.54 times

INTEREST(Q)

Highest at Rs 305.00 cr

Loading Valuation Snapshot...

Here's what is working for Torrent Pharma

Net Sales - Quarterly
Highest at Rs 4,921.00 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 4,921.00 cr has Grown at 40.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 3,495.00 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,664.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 33.81%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Here's what is not working for Torrent Pharma

Interest - Quarterly
At Rs 305.00 cr has Grown at 29.24%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Operating Profit to Interest - Quarterly
Lowest at 5.46 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Quarterly
Highest at Rs 305.00 cr
in the last five quarters and Increased by 29.24 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 1.79 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Lowest at 4.54 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio